Introduction
Thrombotic thrombocytopenic purpura (TTP), a life-threatening syndrome characterized by throm-Thrombotic microangiopathy (TMA) or thrombotic thrombocytopenic purpura (TTP) is a life-threatening syndrome characterized by increased number of fragmented red cells (FRCs) and thrombocytopenia. FRCs can be measured using the recently developed automated hematology analyzer XE-2100. The normal range for FRCs is 0% to 0.205%, as determined by the automated hematology analyzer XE-2100. The FRC count is significantly elevated in patients with TMA associated with liver transplantation, bone marrow transplantation, or TTP. In patients with TMA after liver trans-plantation, the FRC count is significantly higher than in those without TMA. In receiver operating characteristic analysis for the diagnosis of TMA, the area under the curve is 0.986, suggesting that FRC is a useful marker for the diagnosis of TMA. When the cutoff value of FRC for TMA is 1.2%, the sensitivity is 90% and the specificity is 96%, indicating that FRC is the most useful screening test for the diagnosis of TMA.
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Original Articles against ADAMTS13. [10] [11] [12] Although the determination of the ADAMTS13 activity is important in the diagnosis of TTP, it should be noted that a reduction of ADAMTS13 has also been reported in patients with hematopoietic cell transplantation 13 and liver transplantation. 4 Fragmented red cells (FRCs) are often found in the peripheral blood of patients with diseases involving injury to vascular endothelial cells, such as TTP, TMA, and MHA, because of disseminated intravascular coagulation (DIC). Although the FRC level is measurable at the bedside, a visual counting of a peripheral blood smear involves great variance among individual examiners even on the same specimens, and it is time consuming. Recently, the FRC level has been sensitively measured using flow cytometry, in the automated hematology analyzer. [14] [15] [16] [17] In this study, we measured the FRC level in healthy volunteers and in patients with and without TMA to find the cutoff values for the diagnosis of TMA.
Materials and Methods

Patients
Informed consent was obtained from all patients in advance, and the study was approved by the Mie University Review Board for Human Studies. A total of 230 patients-liver transplantation (n = 34; 9 with TMA and 25 without TMA), liver cirrhosis (n = 47), BMT (n = 5), TTP (n = 5), aplastic anemia (AA; n = 8), idiopathic thrombocytopenic purpura (ITP; n = 42), sepsis with DIC (n = 9), sepsis without DIC (n = 61), postchemotherapy (n = 19; acute myeloblastic leukemia [n = 8], acute lymphocytic leukemia [n = 2], chronic myelocytic leukemia [n = 3], malignant lymphoma [n = 4], myelodysplastic syndrome [n = 1], multiple myeloma [n = 1])-and 120 healthy volunteers (36 women and 84 men; median age, 31 years; range, 21-54 years) were analyzed.
ITP was diagnosed as thrombocytopenia with a normal bone marrow and an increased number of megakaryocytes, and the lack of other diseases causing thrombocytopenia. AA was diagnosed as thrombocytopenia, anemia, and leukocytopenia without the presence of another disease causing pancytopenia. The patients treated with chemotherapy were monitored for approximately 60 days after starting the treatment, and the highest FRC values were selected. The diagnosis of TTP or TMA was made based on thrombocytopenia resulting from platelet consumption, MHA, and decreased ADAMTS13 or clinical symptoms such as neurological abnormalities, renal function impairment, and high fever. 9 DIC was diagnosed by the ISTH (International Society on Thrombosis and Haemostasis) overt-DIC diagnostic criteria. 18 
FRC analysis
Approximately 3 mL of peripheral whole blood was obtained by venipuncture into ethylene diamine tetraacetic acid (EDTA)-2K anticoagulant. The FRCs were analyzed using the fully automated hematology analyzer XE-2100 (Sysmex, Kobe, Japan) with specially designed software. The XE-2100 uses flow cytometry and has a semiconductor diode laser to analyze the reticulocytes (RETs). In the RET channel, 2 fluorescent dyes (polymethine and oxazine dye in the RET-SEARCH(II) reagent) penetrate the cell membrane, staining the DNA and RNA of the white blood cells and the RNA in the red blood cells and platelets. The RETs can be distinguished from the mature red blood cells by the differences in the RNA content and from the nucleated cells by the differences in the DNA/RNA content.
In the RET analysis, a low fluorescence intensity and a low intensity of forward light scatter is deemed to be an FRC positive area. It is designed so that the FRC (%) determined from this area has a close relationship with the visually determined FRC (%). See Figure 1 .
Statistical analysis
The data are expressed as the median (95% confidence interval [CI] ). The differences between groups were examined for statistical significance using the Mann-Whitney U test. A P value less than .05 was taken to denote the presence of a statistically significant difference. The usefulness of the FRCs for the diagnosis of TMA was examined using the receiver operating characteristic (ROC) analysis. The cutoff values were determined by ROC analysis. All statistical analyses were performed using the SPSS II software package (SPSS Japan, Tokyo).
Results
In healthy volunteers, FRCs are seldom observed. The median value of the FRC level in healthy participants was 0.04%, with a 95% CI (0%-0.205%). The FRC level was significantly higher in TMA associated with liver transplantation (2.49%; 0.87%-10.56%), BMT (2.40%; 1.32%-5.09%), and TTP (4.91%; 0.91%-9.05%) than in healthy volunteers (P < .01). In the patients with TMA after liver transplantation, the FRC level was significantly higher than in those without TMA (0.40%; 0%-1.13%; P < .01). The FRC level was not significantly higher in patients with liver diseases (0.12%; 0%-1.01%), those with AA (0.27%; 0%-1.36%), those having sepsis with DIC (0.19%; 0%-1.96%) and without DIC (0.19%; 0%-1.61%), patients after chemotherapy (0.36%; 0%-1.35%), and patients with ITP (0.10%; 0%-1.58%) as compared with that in healthy volunteers (Figure 2) . Table 1 shows the hematological parameters in patients with TTP or TMA after liver transplantation or BMT. Figure 3 shows the ROC analysis for the diagnosis of TMA, and the area under the curve is 0.986, suggesting that the FRC level is a useful marker for the diagnosis of TMA. When the cutoff value of the FRC level for TMA is 1.2%, the sensitivity is 90%, specificity is 96%, positive predictive value is 90%, and negative predictive value is 90%. Figure 4A shows the data for a 59-year-old woman with liver cirrhosis caused by the hepatitis B virus. From days 21 to 28 following liver transplantation, the FRC level and the total bilirubin were significantly increased, and the hemoglobulin and platelet counts were markedly reduced. TMA was included in the differential diagnosis. Figure 4B (data for a 60-yearold woman without TMA) does not show a significant increase in the FRC or the total bilirubin nor does it show a significant decrease of the hemoglobulin or platelet counts. Figure 5 shows the changes in the FRC levels in patients with TMA after liver transplantation. The FRC level increased on the day of surgery, and in 5 patients, it was high 10 days after, in 4 patients, 20 days after, in 4 patients, 30 days after, in 4 patients, 40 days after, in 3 patients, 50 days after, and in 2 patients, 60 days after liver transplantation. In all patients, the FRC level in those with TMA was higher than 1.2% during or after liver transplantation.
Discussion
The reported occurrence of TMA in patients receiving an allogenic BMT varies widely from 0% to 74%. [19] [20] [21] [22] [23] As TMA may be a fatal complication in patients with BMT or liver transplantation, it is important to diagnose it in the early phase. The assay of ADAMTS13 is expensive and difficult to do in all patients with BMT or liver transplantation. The measurement of the FRC level is not expensive and is easy to assay using the automated hematology analyzer. A BMT-TMA grading system was developed to assist in early diagnosis based on the percentage of FRCs and lactate dehydrogenase: grade 1, FRC 1.3%; grade 2, FRC 1.3% to 4.8%; grade 3, FRC 4.9% to 9.6%; grade 4, FRC > 9.7%. 24 In our findings, the FRC in 120 healthy volunteers ranged from 0% to 0.21% (95% CI), whereas in those with liver transplantation without TMA and chemotherapy it ranged from 0% to 1.13% and from 0% to 1.35%. The 95% CIs of TTP, TMA resulting from liver transplantation, or BMT were more than 0.91%, 0.87%, or 1.32%, respectively. These findings suggest that the cutoff value of the FRC level for TMA is 1.2%.
The FRC level was significantly higher in patients with TMA caused by liver transplantation or BMT and in those with TTP. Especially after liver transplantation, the FRC level was significantly higher in patients with TMA than in those without TMA, suggesting that the FRC might be useful for the early diagnosis of TMA after liver transplantation. One exception is the low mean corpuscular hemoglobin (MCH) of anemia in some patients with DIC or severe AA. Severe low MCH increases the nonfragmented red blood cells in the FRC area and causes a false positive for FRC. In the evaluation of FRC by the automated hematology analyzer, the MCH should be checked.
TMA may develop in patients after transplantation of bone marrow, 14 liver, 4 and kidney, 25 connective tissue disease such as scleroderma. 26 There are significant differences in the FRC level between those with TMA and those without. Furthermore, TMA occurs from 0 to 60 days after liver transplantation, especially 10 to 40 days after, and it might be frequently associated with liver transplantation. As the FRC level can be determined by a simple assay performed by the automated hematology analyzer, it may be a useful predicting marker for TMA. Furthermore, measurement of the FRC level by the automated hematology analyzer will be required for the screening for TMA after bone marrow or liver transplantation. In an ROC analysis for the diagnosis of TMA, the area under the curve was 0.986, suggesting that the FRC level is a useful marker for the diagnosis of TMA also. When the cutoff value of the FRC level for TMA is 1.2%, the sensitivity is 90%, specificity is 96%, positive predictive value is 90%, and negative predictive value is 90%.
In conclusion, the FRC level is a simple and useful marker for TMA, and an FRC level of 1.2% is recommended as the cutoff value for the diagnosis of TMA. 
